Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer.
Fasano M, Della Corte CM, Di Liello R, Barra G, Sparano F, Viscardi G, Iacovino ML, Paragliola F, Famiglietti V, Ciaramella V, Cimmino F, Capasso M, Iolascon A, Sforza V, Morabito A, Maiello E, Ciardiello F, Morgillo F.
Fasano M, et al. Among authors: della corte cm.
ESMO Open. 2020 Sep;5(5):e000753. doi: 10.1136/esmoopen-2020-000753.
ESMO Open. 2020.
PMID: 32912860
Free PMC article.